Skip to main content
TipRanks
Go Ultimate75% OFF

Kalaris Therapeutics (KLRS) Stock Forecast & Price Target

398 Followers
See the Price Targets and Ratings of:

KLRS Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Kalaris Therapeutics in the past 3 months

KLRS Stock 12 Month Forecast

$20.00▲(952.63% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Kalaris Therapeutics in the last 3 months. The average price target is $20.00 with a high forecast of $20.00 and a low forecast of $20.00. The average price target represents a 952.63% change from the last price of $1.90.
Highest Price Target$20.00Average Price Target$20.00Lowest Price Target$20.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for KLRS
Price TargetArticle
Citizens JMP$25→$20buy952.63%UpsideReiterated11/11/26
Morgan Stanley$14buy636.84%UpsideAssigned08/12/26
William Blair―buy―Reiterated08/11/26
Wedbush$17buy794.74%UpsideAssigned08/11/26
TD Cowen―buy―Initiated06/15/26
Piper Sandler$7hold268.42%UpsideReiterated03/30/26
H.C. Wainwright$19buy900.00%UpsideInitiated12/23/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
MDWDMediwound
IMUXImmunic
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kalaris Therapeutics

3 Months
Success Rate5/12 ratings generated profit
42%
Average Return
+18.37%

Copying Lachlan Hanbury Brown's trades and holding each position for 3 Months would result in 41.67% of your transactions generating a profit, with an average return of +18.37% per trade.

1 Year
Success Rate3/12 ratings generated profit
25%
Average Return
-18.22%

Copying Lachlan Hanbury Brown's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -18.22% per trade.

2 Years
Success Rate1/12 ratings generated profit
8%
Average Return
-42.59%

Copying Lachlan Hanbury Brown's trades and holding each position for 2 Years would result in 8.33% of your transactions generating a profit, with an average return of -42.59% per trade.

KLRS Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for KLRS
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy65421
Buy33210
Hold00000
Sell00000
Strong Sell00000
total98631

In the current month, KLRS has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KLRS average Analyst price target in the past 3 months is 20.00.

KLRS Financial Forecast

$-2$-1.5$-1$-0.5$0Q1 2026Q3 2026Q4 2026
High$-0.47
Consensus$-0.51
Low$-0.57

KLRS Earnings Forecast

Next quarter’s earnings estimate for KLRS is -$0.51 with a range of -$0.57 to -$0.47. The previous quarter’s EPS was -$0.46. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q1 2026Q3 2026Q4 2026
High$0.00
Consensus$0.00
Low$0.00

KLRS Sales Forecast

Next quarter’s sales forecast for KLRS is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

KLRS Stock Forecast FAQ

What is KLRS’s average 12-month price target, according to analysts?
Based on analyst ratings, Kalaris Therapeutics’s 12-month average price target is $20.00.
What is KLRS’s upside potential, based on the analysts’ average price target?
Kalaris Therapeutics has 952.63% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KLRS a Buy, Sell or Hold?
Kalaris Therapeutics has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Kalaris Therapeutics’s price target?
The average price target for Kalaris Therapeutics is $20.00. This is based on 1 12-month price targets, issued in the past 3 months. The highest analyst price target is $20.00, the lowest forecast is $20.00. The average price target represents a 952.63% increase from the current price of $1.9.
What do analysts say about Kalaris Therapeutics?
Kalaris Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of KLRS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.